3D Printing will revolutionize the preparation of personalized medicines in hospitals says Alvaro Goyanes, Co-founder and Director of Development, FabRX. Alvaro will talk about the use of 3D printing for therapy production in a clinical setting at the Online 3D Pharma Printing Conference.. Below you can find a fragment from the abstract of his presentation:
In the pharmaceutical field, the claimed advantages of the in situ fabrication of unit dosage forms with doses and/or drug combinations personalised to the patient may change, in the future, medicines design and manufacture of medicines. It is predicted a change from limited dose range dosage forms manufactured in big industries to tailored-to-patient medicines, to meet the therapeutic needs of each individual patient (precision medicine), prepared in community pharmacies or hospitals. Read more about his presentation here
|